Graham K Ansell

Title: Graham K Ansell: Innovator in Pharmaceutical Chemistry

Introduction

Graham K Ansell is a notable inventor based in Millbury, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 6 patents. His work primarily focuses on developing novel compounds that serve as therapeutics for various medical conditions.

Latest Patents

One of his latest patents involves Octahydropentalene compounds as chemokine receptor antagonists. This invention is directed to novel compounds of Formula (I) and their pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, isomers, or stereoisomers. These compounds are particularly useful in treating inflammatory conditions and diseases, such as rheumatoid arthritis, osteoarthritis, multiple sclerosis, and asthma. Another significant patent pertains to Sphingosine-1-phosphate receptor agonist and antagonist compounds. This invention focuses on novel, potent, and selective agents that act as agonists or antagonists of the S1P receptor family, providing therapeutic options for medical conditions associated with these receptors.

Career Highlights

Graham K Ansell has worked with prominent companies in the pharmaceutical industry, including Abbott Laboratories Corporation and Vertex Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Throughout his career, Ansell has collaborated with notable colleagues, including Adrian Hobson and Shannon R Fix-Stenzel. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Graham K Ansell is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of innovative compounds aimed at treating various medical conditions. His contributions continue to impact the field positively.